Microba Life Sciences (ASX:MAP)
ASX announcement history & article coverage
Transparent by design.
Announcments by Microba Life Sciences (ASX:MAP) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Proposed issue of securities - MAP
Proposed issue of securities - MAP
Q1 FY27 Quarterly Activities Report & Appendix 4C
Microba launches GI Navigator as core revenue rises 31%, while pursuing cost cuts and $2.025m capital raising
Microba secures $2m placement and increases cost reductions
Microba raises $2.025 million as it deepens cost cuts and advances merger plans
Date of AGM and closing date for Director Nominations
Notification of cessation of securities - MAP
Microba launches GI Navigator in Australia and the UK
Change in substantial holding
Appointment of Interim Chief Executive Officer
Microba appoints Geoffrey Cockerill as interim CEO while Luke Reid takes medical leave
2026 Annual Report & Appendix 4E
Microba reports FY26 results with revenue down 5.8%, loss up 38.7%, core testing revenue up 92%, and targets cash flow break-even in 2027
2026 Appendix 4G
2026 Corporate Governance Statement
Change of Director's Interest Notice - Pasquale Rombola
Change of Director's Interest Notice - Prof Ian Frazer
Cleansing Notice
Notification regarding unquoted securities - MAP
Notification regarding unquoted securities - MAP
Application for quotation of securities - MAP
Notification regarding unquoted securities - MAP
Application for quotation of securities - MAP
Completion of Share Purchase Plan
Microba completes $5.41 million capital raising via Placement and Share Purchase Plan
Results of General Meeting